{"url":"https://lda.senate.gov/api/v1/filings/c31df0dd-e7d9-4f33-83e7-b48ec5fcc2ac/","filing_uuid":"c31df0dd-e7d9-4f33-83e7-b48ec5fcc2ac","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c31df0dd-e7d9-4f33-83e7-b48ec5fcc2ac/print/","filing_document_content_type":"text/html","income":null,"expenses":"330000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Gina Cioffi Loud","dt_posted":"2026-04-13T10:25:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"175 Regency Woods Place","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Cary","registrant_state":"NC","registrant_zip":"27518","registrant":{"id":401105793,"url":"https://lda.senate.gov/api/v1/registrants/401105793/","house_registrant_id":null,"name":"CHIESI USA, INC.","description":"Pharmaceutical Company","address_1":"175 Regency Woods Place","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Cary","state":"NC","state_display":"North Carolina","zip":"27518","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GINA CIOFFI LOUD","contact_telephone":"+1 347-680-2938","dt_updated":"2026-07-20T09:43:59.558769-04:00"},"client":{"id":207045,"url":"https://lda.senate.gov/api/v1/clients/207045/","client_id":12,"name":"CHIESI USA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":"NC","ppb_state_display":"North Carolina","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Therapies for Rare Diseases - no specific legislation. General healthcare access and innovation matters, and regulatory pathway topics - no specific legislation.","foreign_entity_issues":"Chiesi Farmaceutici is interested in all issues on line 16.","lobbyists":[{"lobbyist":{"id":81029,"prefix":null,"prefix_display":null,"first_name":"GINA","nickname":null,"middle_name":"CIOFFI","last_name":"LOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148433,"prefix":null,"prefix_display":null,"first_name":"GENTRY","nickname":null,"middle_name":null,"last_name":"LASSITER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}